Orthofix Medical (OFIX) Cash & Current Investments (2009 - 2026)

Orthofix Medical (OFIX) has 18 years of Cash & Current Investments data on file, last reported at $120.9 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Current Investments rose 99.94% year-over-year to $120.9 million; the trailing twelve-month figure through Mar 2026 stood at $120.9 million (up 99.94% YoY), and the FY2025 full-year result was $85.1 million, down 0.73% from the prior year.
• Cash & Current Investments for Q1 2026 stood at $120.9 million, up from $85.1 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $120.9 million in Q1 2026 and bottomed at $28.9 million in Q2 2024.
• A 5-year average of $57.1 million and a median of $51.7 million in 2022 frame the typical range for Cash & Current Investments.
• Across the five-year window, Cash & Current Investments slumped 42.29% in 2022 and soared 137.96% in 2025, its largest moves.
• Tracing OFIX's Cash & Current Investments over 5 years: stood at $50.7 million in 2022, then dropped by 25.53% to $37.8 million in 2023, then jumped by 127.08% to $85.7 million in 2024, then decreased by 0.73% to $85.1 million in 2025, then jumped by 42.01% to $120.9 million in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $120.9 million, $85.1 million, and $65.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison